Article Versions Notes

Markou AN, Londra D, Stergiopoulou D, Vamvakaris I, Potaris K, Pateras IS, Kotsakis A, Georgoulias V, Lianidou E. Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer. Cancers. 2023; 15(6):1877. https://doi.org/10.3390/cancers15061877

Markou, A. N., D. Londra, D. Stergiopoulou, I. Vamvakaris, K. Potaris, I. S. Pateras, A. Kotsakis, V. Georgoulias, and E. Lianidou. 2023. "Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer" Cancers 15, no. 6: 1877. https://doi.org/10.3390/cancers15061877

Markou, A. N., Londra, D., Stergiopoulou, D., Vamvakaris, I., Potaris, K., Pateras, I. S., Kotsakis, A., Georgoulias, V., & Lianidou, E. (2023). Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer. Cancers, 15(6), 1877. https://doi.org/10.3390/cancers15061877